HALO logo
halo search icon
VYNE Therapeutics Inc
VYNE Therapeutics Inc
VYNE · NAS

VYNE Therapeutics Inc

US$0.68

Price Arrow-0.0045 (-0.661%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEngulfing BearishHALO AllHALO Price MomentumNear Resistance
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

VYNE Therapeutics Inc Overview

VYNE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VYNE

icon

Telephone

1.800.755.7936

icon

Address

P.O. Box 125, Stewartsville, NJ 08886

Description

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Stewartsville, NJ.

VYNE Price Chart

Key Stats

Market Cap

US$22.72M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.28 - 1.96

Trade Value (12mth)

US$330,844.00

1 week

1.66%

1 month

6.44%

YTD

17.45%

1 year

-31.89%

All time high

2869.92

Key Fundamentals

EPS 3 yr Growth

-94.50%

EBITDA Margin

NaN%

Operating Cashflow

-$33m

Free Cash Flow Return

-83.00%

ROIC

-67.00%

Interest Coverage

0.00

Quick Ratio

12.50

Other Data

Shares Outstanding (Fully Diluted)

43m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VYNE Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
12 March 26
12 March 26
28 February 26

VYNE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.77-0.94-0.62locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.77-0.94-0.62locklocklock
Growth
%locklocklocklock75.666.233.8locklocklock
PE
Xlocklocklocklock0.7N/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of VYNE Therapeutics Inc (VYNE:NAS)?
Halo FAQ
The current share price of VYNE Therapeutics Inc (VYNE:NAS) is USD$0.68.
What is the 52-week high share price for VYNE Therapeutics Inc (VYNE:NAS)?
Halo FAQ
The 52-week high share price for VYNE Therapeutics Inc (VYNE:NAS) is USD$1.96.
What is the 52-week low share price for VYNE Therapeutics Inc (VYNE:NAS)?
Halo FAQ
The 52-week low share price for VYNE Therapeutics Inc (VYNE:NAS) is USD$0.28.
What is the dividend yield for VYNE Therapeutics Inc (VYNE:NAS)?
Halo FAQ
VYNE Therapeutics Inc (VYNE:NAS) does not pay a dividend.
What was VYNE Therapeutics Inc (VYNE:NAS) last dividend payment?
Halo FAQ
VYNE Therapeutics Inc (VYNE:NAS) does not pay a dividend.
What is the franking level for VYNE Therapeutics Inc (VYNE:NAS)?
Halo FAQ
VYNE Therapeutics Inc (VYNE:NAS) has a franking level of 0.00%.
In which sector is VYNE Therapeutics Inc (VYNE:NAS) classified?
Halo FAQ
VYNE Therapeutics Inc (VYNE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.